Literature DB >> 3422830

Characteristics and expression of binding sites specific for ferritin H-chain on human cell lines.

S Fargion1, P Arosio, A L Fracanzani, V Cislaghi, S Levi, A Cozzi, A Piperno, G Fiorelli.   

Abstract

Purified recombinant human ferritin composed solely of H subunit was radiolabeled and incubated with proerythroleukemic K562 human cells. A specific binding was detected, and it could be displaced only by ferritins, natural or recombinant, containing large proportion of the H subunit. The specific ferritin H-chain binding was saturable, and cells showed 17,000 to 23,000 binding sites per cell. The affinity constant measured at 37 degrees C was of 3 x 10(8) M-1. Treatment with pronase eliminated the specific binding. The binding sites were expressed in a high number during the cellular exponential phase of growth and progressively decreased to disappear when cells reached the plateau phase. Treatment of the cells with desferrioxamine increased recombinant H-ferritin binding, while iron had little effect. K562 cells induced to differentiate by hemin failed to bind ferritin H. Ferritin H-chain binding capacity is present on various cell lines such as HL60, lung cancer, and hepatoma cells. Analysis of the binding sites by western blotting showed a peptide with apparent mol wt of about 100 kd.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422830

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Binding and uptake of H-ferritin are mediated by human transferrin receptor-1.

Authors:  Li Li; Celia J Fang; James C Ryan; Eréne C Niemi; José A Lebrón; Pamela J Björkman; Hisashi Arase; Frank M Torti; Suzy V Torti; Mary C Nakamura; William E Seaman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-04       Impact factor: 11.205

2.  Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release.

Authors:  Narayanan Parthasarathy; Suzy V Torti; Frank M Torti
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

3.  Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: a link between ferritin ferroxidase activity and biological function.

Authors:  H E Broxmeyer; S Cooper; S Levi; P Arosio
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

4.  Iron uptake mediated by binding of H-ferritin to the TIM-2 receptor in mouse cells.

Authors:  Jian Han; William E Seaman; Xiumin Di; Wei Wang; Mark Willingham; Frank M Torti; Suzy V Torti
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

5.  TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer.

Authors:  Xiaojing Cheng; Kelong Fan; Lin Wang; Xiangji Ying; Andrew J Sanders; Ting Guo; Xiaofang Xing; Meng Zhou; Hong Du; Ying Hu; Huirong Ding; Ziyu Li; Xianzi Wen; Wenguo Jiang; Xiyun Yan; Jiafu Ji
Journal:  Cell Death Dis       Date:  2020-02-05       Impact factor: 8.469

6.  H-Ferritin Is Preferentially Incorporated by Human Erythroid Cells through Transferrin Receptor 1 in a Threshold-Dependent Manner.

Authors:  Soichiro Sakamoto; Hiroshi Kawabata; Taro Masuda; Tatsuki Uchiyama; Chisaki Mizumoto; Katsuyuki Ohmori; H Phillip Koeffler; Norimitsu Kadowaki; Akifumi Takaori-Kondo
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.